Product Detail
2-Chlorobenzhydrol-d5
Stable Isotope Reagent
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotope Reagent
API Family
--
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
2-Chlorobenzhydrol-d5 Product Information
2-Chlorobenzhydrol-d5 is listed under Stable Isotope Reagent. It is associated with - and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103865.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
2-Chlorobenzhydrol-d5
CAS No.
6954-45-6(unlabelled)
CAT No.
CS-T-103865
Molecular Formula
C₁₃H₆D₅ClO
Molecular Weight
223.71
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
OC(C1=C([2H])C([2H])=C([2H])C([2H])=C1[2H])C2=C(Cl)C=CC=C2
IUPAC Name
(2-Chlorophenyl)phenylmethanol-d5
Hazard Compound
Refer MSDS for complete information.
Description
Overview
2-Chlorobenzhydrol-d5 is the isotope labelled analog of 2-Chlorobenzhydrol (C427550); a reagent in the synthesis of bifonazole analogs which have antibacterial and antifungal activities. 2-Chlorobenzhydrol is also a reagent in the preparation of cinnamyl piperazine derivatives which have anticonvulsant activity.
Synonyms
(2-Chlorophenyl)phenylmethanol-d5; (±)-(2-Chlorophenyl)phenylmethanol-d5; 2-Chloro-α-phenylbenzenemethanol-d5; Mono-o-chlorodiphenylcarbinol-d5; NSC 37575-d5
Application Notes
2-Chlorobenzhydrol-d5 is the isotope labelled analog of 2-Chlorobenzhydrol (C427550); a reagent in the synthesis of bifonazole analogs which have antibacterial and antifungal activities. 2-Chlorobenzhydrol is also a reagent in the preparation of cinnamyl piperazine derivatives which have anticonvulsant activity.
References
El Hage, S., et al.: Arch. Pharm., 344, 402 (2011); Hu, C., et al.: Lett. Drug Des. Discov., 7, 661 (2010)